- Home
- VRAX vs SGN Comparison
VRAX vs SGN Comparison
Compare VRAX & SGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- SGN
- Stock Information
- Founded
- VRAX 2013
- SGN 2019
- Country
- VRAX United Kingdom
- SGN United States
- Employees
- VRAX N/A
- SGN N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SGN
- Sector
- VRAX Health Care
- SGN
- Exchange
- VRAX Nasdaq
- SGN Nasdaq
- Market Cap
- VRAX 4.4M
- SGN 3.8M
- IPO Year
- VRAX 2022
- SGN 2023
- Fundamental
- Price
- VRAX $0.95
- SGN $1.52
- Analyst Decision
- VRAX Strong Buy
- SGN
- Analyst Count
- VRAX 1
- SGN 0
- Target Price
- VRAX $3.00
- SGN N/A
- AVG Volume (30 Days)
- VRAX 155.0K
- SGN 7.0M
- Earning Date
- VRAX 02-05-2025
- SGN 08-18-2025
- Dividend Yield
- VRAX N/A
- SGN N/A
- EPS Growth
- VRAX N/A
- SGN N/A
- EPS
- VRAX N/A
- SGN N/A
- Revenue
- VRAX $6,331.00
- SGN $529,282.00
- Revenue This Year
- VRAX $217,274.83
- SGN N/A
- Revenue Next Year
- VRAX N/A
- SGN N/A
- P/E Ratio
- VRAX N/A
- SGN N/A
- Revenue Growth
- VRAX N/A
- SGN 8.42
- 52 Week Low
- VRAX $0.74
- SGN $0.44
- 52 Week High
- VRAX $9.00
- SGN $36.70
- Technical
- Relative Strength Index (RSI)
- VRAX 51.51
- SGN 49.12
- Support Level
- VRAX $0.86
- SGN $1.44
- Resistance Level
- VRAX $1.10
- SGN $2.27
- Average True Range (ATR)
- VRAX 0.11
- SGN 0.35
- MACD
- VRAX 0.01
- SGN -0.06
- Stochastic Oscillator
- VRAX 35.48
- SGN 21.33
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.